Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease

Keyphrases

• Alzheimer's Disease 100%
• Amyloid beta 100%
• Tau Protein 100%
• Amyloid-β Peptide 100%
• Neurodegeneration 20%
• Cognitive Decline 20%
• Neuronal Loss 20%
• Amyloid Accumulation 20%
• Tau Hyperphosphorylation 20%
• Tau Immunotherapy 20%
• Clinical Trials 10%
• Neurodegenerative Diseases 10%
• Amyloid Plaques 10%
• Synaptic Dysfunction 10%
• Disease Stage 10%
• Synaptic Function 10%
• Scientific Community 10%
• Immune System 10%
• Inflammation 10%
• Evidence Support 10%
• Dementia 10%
• Tau Pathology 10%
• Tau Aggregation 10%
• Clinical Symptoms 10%
• Neurofibrillary Tangles 10%
• Cognitive Behavior 10%
• Apolipoprotein E 10%
• Tau Levels 10%
• Amyloid-β Pathology 10%
• Behavioral Abnormalities 10%
• Amyloid Cascade Hypothesis 10%
• Dual Pathway 10%
• Direct Therapy 10%
• Effector Molecules 10%
• Transcriptional Perturbation 10%
• Tau Neurofibrillary Tangles 10%

Neuroscience

• Beta Amyloid 100%
• Tau Protein 100%
• Alzheimer's Disease 100%
• Amyloid Beta Protein 100%
• Immunotherapy 30%
• Neurodegeneration 15%
• Amyloid Protein 15%
• Hyperphosphorylation 15%
• Neurodegenerative Disorder 7%
• Apolipoprotein E 7%

Biochemistry, Genetics and Molecular Biology

• Beta-Peptide 100%
• Amyloid Beta 100%
• Tau Protein 100%
• Tau 92%
• Neurofibrillary Tangle 14%
• Hyperphosphorylation 14%
• Amyloid Protein 14%
• Isoform 7%
• Animal Models 7%
• Transcription 7%
• Clinical Trial 7%
• Immunity 7%
• Downregulation 7%
• Apolipoprotein E 7%